Dyslipidemia and its associated factors in patients with type 2 diabetes mellitus

The pattern of dyslipidaemia and factors associated with elevated levels of non-HDL-cholesterol among patients with type 2 diabetes mellitus in the Ho municipality: A cross sectional study

“…In the present study, we found a high rate of dyslipidaemia [114 (67.1%)] among the study respondents ( Table 3 ) similar to those reported previously in Ho (3–42%) [ 18 ] and Kumasi (63%) [ 31 ]. The mechanism that underlies dyslipidaemia in diabetes mellitus is complex.…”

“…Till date, there is no comprehensive literature on the characteristic pattern of dyslipidaemia among Ghanaians, and in particular, patients with type 2 diabetes mellitus in the Volta Region, although a few reports of high dyslipidaemia prevalence have been documented previously in the Ho municipality [ 18 , 19 ]. Besides, understanding the dynamics in dyslipidaemia patterns could inform appropriate clinical interventions in mitigating adverse events of cardiovascular origin and associated complications.…”

Factors associated with lipid control in outpatients with heart failure

“…A study conducted in Spain reported that poor low-density lipoprotein (LDL) cholesterol control was recognized in nearly 60% of the patients with a cardiovascular disease ( 18 ). Another study conducted in Ghana among patients with type 2 diabetes found that more than one third of the participating patients had high total cholesterol and LDL levels ( 27 ). Suboptimal lipid control was also recognized in patients with premature coronary artery disease (CAD) participated in a Mexican study using two different criteria for lipid control assessment ( 28 ).…”

Frequency and factors associated with dyslipidemia among people with type 2 Diabetes Mellitus / Frequência e fatores associados à dislipidemia entre pessoas com diabetes mellitus tipo 2

“…People with DM2, especially those with poorly controlled glucose levels, are more prone to elevated lipid levels. 3,10 In this research, there was a predominance of females and a higher prevalence of dyslipidemia among women. A population--based epidemiological study conducted in Brazil with 60,202 people showed that at least 15% of the women investigated had dyslipidemia.…”

“…When poorly controlled, DM2 also affects the lipid metabolism of the patient with the disease and can lead to dyslipidemia. [1][2][3] Added to this, the person with diabetes also tends to have an accumulation of adiposity that, in turn, generates a pro--inflammatory state, insulin resistance, and increases the risk of developing atherosclerosis and other major cardiovascular complications. Such an imbalance can lead to dysregulation of the immune system, facilitating infection of the patient by infectious diseases, such as COVID-19.…”